Patent 11746334 was granted and assigned to Mayo Foundation for Medical Education and Research (MFMER) on September, 2023 by the United States Patent and Trademark Office.
This invention relates to methods and materials for nucleic acid delivery, vaccination, and/or treating cancer. More specifically, methods and materials for nucleic acid delivery, vaccination, and/or treating cancer using one or more recombinant adenoviruses (Ads) as an oncolytic agent are provided.